Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of lipid biosynthetic process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.802 | Human | |
HNF4A | hepatocyte nuclear factor 4, alpha | 0.780 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.758 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.662 | ||
AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.657 | Human | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.492 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.462 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.425 | Human | |
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.399 | Human | |
BMPR1A | bone morphogenetic protein receptor, type IA | 0.377 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.361 | ||
APOA1 | apolipoprotein A-I | 0.279 | Human | |
NCOR2 | nuclear receptor corepressor 2 | 0.244 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.220 | Human | |
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.177 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.172 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.165 | ||
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.148 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.138 | Human | |
VEGFA | vascular endothelial growth factor A | 0.136 | Human | |
NRP1 | neuropilin 1 | 0.086 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.083 | ||
HP | haptoglobin | 0.080 | ||
ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.075 | ||
APOC1 | apolipoprotein C-I | 0.068 | ||
APOE | apolipoprotein E | 0.066 | ||
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.064 | ||
ALB | albumin | 0.057 | ||
BMPR1B | bone morphogenetic protein receptor, type IB | 0.057 | ||
LDLR | low density lipoprotein receptor | 0.054 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.052 | ||
SREBF2 | sterol regulatory element binding transcription factor 2 | 0.047 | ||
A2M | alpha-2-macroglobulin | 0.047 | ||
RXRA | retinoid X receptor, alpha | 0.044 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.042 | ||
KLB | klotho beta | 0.039 | ||
NOG | noggin | 0.034 | ||
HR | hairless homolog (mouse) | 0.033 | ||
PRDX1 | peroxiredoxin 1 | 0.030 | ||
RARA | retinoic acid receptor, alpha | 0.028 | ||
ATF5 | activating transcription factor 5 | 0.027 | ||
PGF | placental growth factor | 0.024 | Human | |
COL2A1 | collagen, type II, alpha 1 | 0.022 | ||
APOC3 | apolipoprotein C-III | 0.021 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.021 | ||
WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.021 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.021 | ||
APOA2 | apolipoprotein A-II | 0.020 | ||
FGF18 | fibroblast growth factor 18 | 0.020 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.019 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.019 | ||
ESRRG | estrogen-related receptor gamma | 0.019 | ||
EP300 | E1A binding protein p300 | 0.018 | ||
PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.017 | ||
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.016 | ||
JAG2 | jagged 2 | 0.015 | ||
APOC2 | apolipoprotein C-II | 0.015 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.015 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.014 | ||
MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.014 | ||
NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.014 | ||
WNT11 | wingless-type MMTV integration site family, member 11 | 0.013 | Human | |
FGA | fibrinogen alpha chain | 0.013 | ||
SMAD9 | SMAD family member 9 | 0.013 | ||
CCDC6 | coiled-coil domain containing 6 | 0.013 | ||
EGR1 | early growth response 1 | 0.013 | ||
LCAT | lecithin-cholesterol acyltransferase | 0.013 | ||
NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.012 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.012 | ||
FGF4 | fibroblast growth factor 4 | 0.012 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.012 | ||
CCNE1 | cyclin E1 | 0.012 | ||
NOTCH1 | notch 1 | 0.012 | ||
BTRC | beta-transducin repeat containing | 0.012 | ||
CREBBP | CREB binding protein | 0.012 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.011 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.011 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.011 | ||
WIF1 | WNT inhibitory factor 1 | 0.011 | ||
APOC4 | apolipoprotein C-IV | 0.011 | ||
FSTL1 | follistatin-like 1 | 0.011 | ||
FBLN1 | fibulin 1 | 0.011 | ||
NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.011 | ||
GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.010 | ||
ACAA1 | acetyl-CoA acyltransferase 1 | 0.010 | ||
RRN3 | RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) | 0.010 | ||
RCOR1 | REST corepressor 1 | 0.010 | ||
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.010 |